Expanded Indication News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expanded indication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expanded Indication Today - Breaking & Trending Today

May is Hepatitis Awareness Month

Hepatitis Awareness Month is designed to raise awareness of viral hepatitis and promote testing and vaccination while decreasing the stigma against the virus. ....

United States , Gilead Sciences Inc , Us Preventive Services Task , Gilead Sciences , Hepatitis Awareness Month , Hepatitis Testing , Services Task Force , Ongoing Global Management , Expanded Indication , Tenofovir Alafenamide , Disease Focus , Hepatitisc Treatment ,

Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results

Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines

Fourth-Quarter Worldwide Sales Were $14.6 Billion, an Increase of 6% From Fourth Quarter 2022; Excluding. ....

United States , Adempas Verquvo , Patritumab Deruxtecan , Robertm Davis , Daiichi Sankyo Biologics , Daiichi Sankyo , Human Health , Afferent Pharmaceuticals , Exchange Commission , Merck Co Inc , Restructuring Program , Moderna Inc , Drug Administration , Net Income Attributable To Merck Co Inc , Prometheus Biosciences Inc , Harpoon Therapeutics Inc , Orion Corporation , Imago Biosciences Inc , Statement Of Merck Co Inc , European Commission , Us Centers For Disease , Merck Co , Animal Health , Alliance Revenue , Accepted Accounting Principles , Companion Animal ,

SI-Bone gets clearance for smaller version of spine implant

SI-Bone earned FDA 510(k) clearance of the iFuse Bedrock Granite implant system in a smaller diameter, according to a Jan. 30 news release. ....

Technology Payment , Fuse Bedrock Granite , Breakthrough Device Designation , New Technology Add On Payment , Si Bone , Da 510k Clearance , Maller Diameter , Expanded Indication , Pediatric Patients , 1 Trajectory , Sacroiliac Fusion ,

U.S. Food and Drug Administration Approves BioMarin's VOXZOGO® (vosoritide) for Children Under 5 Years with Achondroplasia

/PRNewswire/ BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today. ....

Andrew Villani , Traci Mccarty , Biomarin Rareconnections , Hank Fuchs , William Wilcox , Committee For Medicinal Products Human Use , Biomarin Pharmaceutical Inc , European Commission , Emory University , Worldwide Research , European Medicines Agency , Drug Administration , Exchange Commission , Expanded Indication , Includes Children , Biomarin Pharmaceutical , New Drug Application , Paediatric Endocrinology Meeting , Medicinal Products , Human Use , Drug Designation , Case Manager , Biomarin Medical Information , Prescribing Information , Quarterly Report , Marin Pharmaceutical ,

NeuroStar Achieves Milestone Regulatory Clearance in South Korea

First International Approval for Expanded Indication and Certification for MT Cap and D-Tect™ TechnologiesMALVERN, Pa., July 17, 2023 Neuronetics, Inc. , a medical technology company focused. ....

South Korea , United States , South Korean , Keithj Sullivan , Neurostar Advanced Therapy For Mental Health , Neuronetics Inc , Public Health , Ministry Of Food , First International Approval For Expanded Indication , Organization Of Economic Cooperation , First International Approval , Expanded Indication , Drug Safety , Economic Cooperation , Neurostar Advanced Therapy , General Population ,